PubMed

Defining the Optimal Treatment for Clinical Stage I Nonseminomatous Germ Cell Testicular Cancer Using Decision Analysis.

Nguyen CT, Fu AZ, Gilligan TD, Wells BJ, Klein EA, Kattan MW, Stephenson AJ.

J Clin Oncol. 2009 Nov 16. [Epub ahead of print]PMID: 19917846 [PubMed - as supplied by publisher]Related articles

Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy.

Schroeck FR, Kattan MW, Moul JW, Aronson WJ, Presti Jr JC, Terris MK, Kane CJ, Amling CL, Sun L, Freedland SJ.

BJU Int. 2009 Nov 13. [Epub ahead of print]PMID: 19912203 [PubMed - as supplied by publisher]Related articles

Why Can't Nomograms Be More Like Netflix?

Vickers AJ, Fearn P, Scardino PT, Kattan MW.

Urology. 2009 Oct 29. [Epub ahead of print] No abstract available. PMID: 19879636 [PubMed - as supplied by publisher]Related articles

Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.

Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, Kattan MW, Monfardini S, Moul JW, Naeim A, van Poppel H, Saad F, Sternberg CN.

Crit Rev Oncol Hematol. 2009 Oct 15. [Epub ahead of print]PMID: 19836968 [PubMed - as supplied by publisher]Related articles

Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.

Vickers AJ, Cronin AM, Kattan MW, Gonen M, Scardino PT, Milowsky MI, Dalbagni G, Bochner BH; for The International Bladder Cancer Nomogram ConsortiumThe following are members of the International Bladder Cancer Nomogram Consortium: Bernard H. Bochner, MD (director); Guido Dalbagni, MD (codirector); Statistical Group: Michael W. Kattan, PhD (director); Paul Fearn (bioinformatics coordinator), Kinjal Vora, Hee Song Seo, and Lauren Zoref; Mansura University: Hassan Abol‐Enein and Mohamed A. Ghoneim; Memorial Sloan‐Kettering Cancer Center: Bernard H. Bochner, Guido Dalbagni, Peter T. Scardino, and Dean Bajorin; University of Southern California: Donald G. Skinner, John P. Stein, and Gus Miranda; Ulm University: Jürgen E. Gschwend, MD; Bjoern G. Volkmer, MD; and Richard E. Hautmann, MD; Vanderbilt University: Sam Chang, Michael Cookson, and Joseph A. Smith; University of Bern: George Thalman and Urs E. Studer; University of Michigan: Cheryl T. Lee, James Montie, and David Wood; Fundació Puigvert: Juan Palou, Humberto Villavicencio, and Antonio Rosales; Laval University: Yyes Fradet, Louis LaCombe, and Pierre Simard; Johns Hopkins Medical Center: Mark P. Schoenberg; Baylor College of Medicine: Seth Lerner and Amnon Vazina; University of Padova Medical School: Pier‐Francesco Bassi; and Keio University: Masaru Murai and Eiji Kikuchi..

Cancer. 2009 Oct 12;115(23):5460-5469. [Epub ahead of print]PMID: 19823979 [PubMed - as supplied by publisher]Related articles

Predicting Patient Discharge Disposition After Total Joint Arthroplasty in the United States.

Barsoum WK, Murray TG, Klika AK, Green K, Miniaci SL, Wells BJ, Kattan MW.

J Arthroplasty. 2009 Sep 1. [Epub ahead of print]PMID: 19729270 [PubMed - as supplied by publisher]Related articles

The Ultimate Prostate Cancer Biopsy Decision Support Tool.

Kattan MW, Jones JS.

Eur Urol. 2009 Aug 26. [Epub ahead of print] No abstract available. PMID: 19720450 [PubMed - as supplied by publisher]Related articles

Editorial comment.

Kattan MW.

Urology. 2009 Sep;74(3):664. No abstract available. PMID: 19716925 [PubMed - indexed for MEDLINE]Related articles

Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy.

Stephenson AJ, Wood DP, Kattan MW, Klein EA, Scardino PT, Eastham JA, Carver BS.

J Urol. 2009 Oct;182(4):1357-63. Epub 2009 Aug 14.PMID: 19683274 [PubMed - indexed for MEDLINE]Related articles

A nomogram for predicting upgrading in patients with low- and intermediate-grade prostate cancer in the era of extended prostate sampling.

Moussa AS, Kattan MW, Berglund R, Yu C, Fareed K, Jones JS.

BJU Int. 2009 Aug 13. [Epub ahead of print]PMID: 19681898 [PubMed - as supplied by publisher]Related articles

Use of Nomograms for Personalized Decision-Analytic Recommendations.

Fu AZ, Cantor SB, Kattan MW.

Med Decis Making. 2009 Jul 31. [Epub ahead of print]PMID: 19648535 [PubMed - as supplied by publisher]Related articles

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

Stephenson AJ, Kattan MW, Eastham JA, Bianco FJ Jr, Yossepowitch O, Vickers AJ, Klein EA, Wood DP, Scardino PT.

J Clin Oncol. 2009 Sep 10;27(26):4300-5. Epub 2009 Jul 27.PMID: 19636023 [PubMed - indexed for MEDLINE]Related articles

Validation of Two Preoperative Kattan Nomograms Predicting Recurrence After Radical Prostatectomy for Localized Prostate Cancer in Turkey: A Multicenter Study of the Uro-oncology Society.

Sy E, L T, E K, C C, H A, S B, K B; Turkish Validation Study Group of Kattan Preoperative Nomogram,, Mw K, H O.

Urology. 2009 Jul 7. [Epub ahead of print]PMID: 19589584 [PubMed - as supplied by publisher]Related articles

Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling.

Nguyen CT, Kattan MW.

Cancer. 2009 Jul 1;115(13 Suppl):3039-45.PMID: 19544545 [PubMed - indexed for MEDLINE]Related articles

The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.

Nguyen CT, Zelefsky MJ, Kattan MW.

Cancer. 2009 Jul 1;115(13 Suppl):3121-7. Review.PMID: 19544540 [PubMed - indexed for MEDLINE]Related articles

Postoperative Nomogram Predicting the 9-Year Probability of Prostate Cancer Recurrence After Permanent Prostate Brachytherapy Using Radiation Dose as a Prognostic Variable.

Potters L, Roach M 3rd, Davis BJ, Stock RG, Ciezki JP, Zelefsky MJ, Stone NN, Fearn PA, Yu C, Shinohara K, Kattan MW.

Int J Radiat Oncol Biol Phys. 2009 Jun 17. [Epub ahead of print]PMID: 19540064 [PubMed - as supplied by publisher]Related articles

Prediction models for transitional cell carcinoma.

Kattan MW.

J Urol. 2009 Aug;182(2):423-4. Epub 2009 Jun 13. No abstract available. PMID: 19524952 [PubMed - indexed for MEDLINE]Related articles

Challenges in clinical prostate cancer: role of imaging.

Kelloff GJ, Choyke P, Coffey DS; Prostate Cancer Imaging Working Group.

AJR Am J Roentgenol. 2009 Jun;192(6):1455-70.PMID: 19457806 [PubMed - indexed for MEDLINE]Related articles

Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study.

Berney DM, Gopalan A, Kudahetti S, Fisher G, Ambroisine L, Foster CS, Reuter V, Eastham J, Moller H, Kattan MW, Gerald W, Cooper C, Scardino P, Cuzick J.

Br J Cancer. 2009 Mar 24;100(6):888-93.PMID: 19293807 [PubMed - indexed for MEDLINE]Related articles

p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer.

Kudahetti S, Fisher G, Ambroisine L, Foster C, Reuter V, Eastham J, Møller H, Kattan MW, Cooper CS, Scardino P, Cuzick J, Berney DM.

BJU Int. 2009 Jul;104(1):20-4. Epub 2009 Feb 23.PMID: 19239456 [PubMed - indexed for MEDLINE]Related articles

Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.

Fuchsjäger MH, Shukla-Dave A, Hricak H, Wang L, Touijer K, Donohue JF, Eastham JA, Kattan MW.

BJU Int. 2009 Aug;104(3):315-20. Epub 2009 Feb 11.PMID: 19220263 [PubMed - indexed for MEDLINE]Related articles

The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.

Pantalone KM, Kattan MW, Yu C, Wells BJ, Arrigain S, Jain A, Atreja A, Zimmerman RS.

Acta Diabetol. 2009 Jun;46(2):145-54. Epub 2009 Feb 5.PMID: 19194648 [PubMed - indexed for MEDLINE]Related articles

Nomograms for predicting graft function and survival in living donor kidney transplantation based on the UNOS Registry.

Tiong HY, Goldfarb DA, Kattan MW, Alster JM, Thuita L, Yu C, Wee A, Poggio ED.

J Urol. 2009 Mar;181(3):1248-55. Epub 2009 Jan 23.PMID: 19167732 [PubMed - indexed for MEDLINE]Related articles

Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer.

Kattan MW, Vickers AJ, Yu C, Bianco FJ, Cronin AM, Eastham JA, Klein EA, Reuther AM, Edson Pontes J, Scardino PT.

Cancer. 2009 Mar 1;115(5):1005-10.PMID: 19156928 [PubMed - indexed for MEDLINE]Related articles

Prognostic models and algorithms in renal cell carcinoma.

Lane BR, Kattan MW.

Urol Clin North Am. 2008 Nov;35(4):613-25; vii. Review.PMID: 18992615 [PubMed - indexed for MEDLINE]Related articles

Predictive modeling in prostate cancer: a conference summary.

Valdagni R, Scardino PT, Denis L, Kattan MW.

Eur Urol. 2009 Feb;55(2):300-2. Epub 2008 Sep 17. No abstract available. PMID: 18834662 [PubMed - indexed for MEDLINE]Related articles

An updated catalog of prostate cancer predictive tools.

Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW.

Cancer. 2008 Dec 1;113(11):3075-99. Review.PMID: 18823041 [PubMed - indexed for MEDLINE]Related articles

Predicting 6-year mortality risk in patients with type 2 diabetes.

Wells BJ, Jain A, Arrigain S, Yu C, Rosenkrans WA Jr, Kattan MW.

Diabetes Care. 2008 Dec;31(12):2301-6. Epub 2008 Sep 22.PMID: 18809629 [PubMed - indexed for MEDLINE]Related articlesFree article

Utilities should not be multiplied: evidence from the preference-based scores in the United States.

Fu AZ, Kattan MW.

Med Care. 2008 Sep;46(9):984-90.PMID: 18725854 [PubMed - indexed for MEDLINE]Related articles

Nomogram for deciding adjuvant treatment after surgery for oral cavity squamous cell carcinoma.

Gross ND, Patel SG, Carvalho AL, Chu PY, Kowalski LP, Boyle JO, Shah JP, Kattan MW.

Head Neck. 2008 Oct;30(10):1352-60.PMID: 18720518 [PubMed - indexed for MEDLINE]Related articles

Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma.

Motzer RJ, Bukowski RM, Figlin RA, Hutson TE, Michaelson MD, Kim ST, Baum CM, Kattan MW.

Cancer. 2008 Oct 1;113(7):1552-8.PMID: 18720362 [PubMed - indexed for MEDLINE]Related articlesFree article

Against diagnosis.

Vickers AJ, Basch E, Kattan MW.

Ann Intern Med. 2008 Aug 5;149(3):200-3.PMID: 18678847 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature.

Shariat SF, Karakiewicz PI, Suardi N, Kattan MW.

Clin Cancer Res. 2008 Jul 15;14(14):4400-7. Review.PMID: 18628454 [PubMed - indexed for MEDLINE]Related articlesFree article

Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy.

Stone NN, Potters L, Davis BJ, Ciezki JP, Zelefsky MJ, Roach M, Shinohara K, Fearn PA, Kattan MW, Stock RG.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):341-6. Epub 2008 Jul 1.PMID: 18597953 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis: Its strengths and limitations.

Walker E, Hernandez AV, Kattan MW.

Cleve Clin J Med. 2008 Jun;75(6):431-9. Review.PMID: 18595551 [PubMed - indexed for MEDLINE]Related articlesFree article

Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.

Hernandez AV, Walker E, Ioannidis JP, Kattan MW.

Am Heart J. 2008 Jul;156(1):23-30. Epub 2008 May 5. Review.PMID: 18585493 [PubMed - indexed for MEDLINE]Related articles

How accurate are present risk group assignment tools in penile cancer?

Ficarra V, Novara G, Boscolo-Berto R, Artibani W, Kattan MW.

World J Urol. 2009 Apr;27(2):155-60. Epub 2008 Jun 17. Review.PMID: 18560836 [PubMed - indexed for MEDLINE]Related articles

Should I use this nomogram?

Kattan MW.

BJU Int. 2008 Aug;102(4):421-2. Epub 2008 Jun 4. No abstract available. PMID: 18537957 [PubMed - indexed for MEDLINE]Related articles

The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review.

Schröder F, Kattan MW.

Eur Urol. 2008 Aug;54(2):274-90. Epub 2008 May 22. Review.PMID: 18511177 [PubMed - indexed for MEDLINE]Related articles

Do we need more nomograms for predicting outcomes in patients with prostate cancer?

Kattan MW.

Nat Clin Pract Urol. 2008 Jul;5(7):366-7. Epub 2008 May 27. No abstract available. PMID: 18506152 [PubMed - indexed for MEDLINE]Related articles

Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice.

Dong F, Kattan MW, Steyerberg EW, Jones JS, Stephenson AJ, Schröder FH, Klein EA.

J Urol. 2008 Jul;180(1):150-4; discussion 154. Epub 2008 May 15.PMID: 18485398 [PubMed - indexed for MEDLINE]Related articles

The prediction philosophy in statistics.

Kattan MW, Gönen M.

Urol Oncol. 2008 May-Jun;26(3):316-9. Epub 2007 Nov 7.PMID: 18452827 [PubMed - indexed for MEDLINE]Related articles

Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.

Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, Slawin K, Scardino PT.

J Urol. 2008 May;179(5 Suppl):S47-51.PMID: 18405751 [PubMed]Related articles

Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time.

Arlen PM, Bianco F, Dahut WL, D'Amico A, Figg WD, Freedland SJ, Gulley JL, Kantoff PW, Kattan MW, Lee A, Regan MM, Sartor O; Prostate Specific Antigen Working Group.

J Urol. 2008 Jun;179(6):2181-5; discussion 2185-6. Epub 2008 Apr 18.PMID: 18423743 [PubMed - indexed for MEDLINE]Related articlesFree article

Preoperative nomogram predicting 12-year probability of metastatic renal cancer.

Raj GV, Thompson RH, Leibovich BC, Blute ML, Russo P, Kattan MW.

J Urol. 2008 Jun;179(6):2146-51; discussion 2151. Epub 2008 Apr 18.PMID: 18423735 [PubMed - indexed for MEDLINE]Related articles

Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories.

Klein EA, Bianco FJ, Serio AM, Eastham JA, Kattan MW, Pontes JE, Vickers AJ, Scardino PT.

J Urol. 2008 Jun;179(6):2212-6; discussion 2216-7. Epub 2008 Apr 18.PMID: 18423716 [PubMed - indexed for MEDLINE]Related articles

Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.

Eastham JA, Scardino PT, Kattan MW.

J Urol. 2008 Jun;179(6):2207-10; discussion 2210-1. Epub 2008 Apr 18.PMID: 18423693 [PubMed - indexed for MEDLINE]Related articles

Inventory of prostate cancer predictive tools.

Shariat SF, Karakiewicz PI, Margulis V, Kattan MW.

Curr Opin Urol. 2008 May;18(3):279-96. Review.PMID: 18382238 [PubMed - indexed for MEDLINE]Related articles

The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.

Karakiewicz PI, Bhojani N, Neugut A, Shariat SF, Jeldres C, Graefen M, Perrotte P, Peloquin F, Kattan MW.

J Sex Med. 2008 Apr;5(4):919-27.PMID: 18371045 [PubMed - indexed for MEDLINE]Related articles

Predicting prostate cancer behavior--what is a urologist to do?

Kattan MW.

J Urol. 2008 May;179(5):1658-9. Epub 2008 Mar 17. No abstract available. PMID: 18343424 [PubMed - indexed for MEDLINE]Related articles